Free Trial
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.01
$0.04
▼
$0.19
$653K0.311,976 shsN/A
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
$2.20
$2.71
$2.04
▼
$21.75
$1.76M1.431,923 shs19,330 shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$0.15
$0.25
$0.13
▼
$3.42
$2.11M6.117.52 million shs666,287 shs
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$2.82
$4.36
$2.38
▼
$55.60
$2.71M0.2185,119 shs17,731 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00%0.00%0.00%0.00%-83.50%
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
0.00%-7.56%-16.35%-29.26%-85.72%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
0.00%+7.89%-18.56%-68.54%-95.24%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
0.00%-1.05%-20.11%-67.88%-94.20%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.01
$0.04
▼
$0.19
$653K0.311,976 shsN/A
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
$2.20
$2.71
$2.04
▼
$21.75
$1.76M1.431,923 shs19,330 shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$0.15
$0.25
$0.13
▼
$3.42
$2.11M6.117.52 million shs666,287 shs
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$2.82
$4.36
$2.38
▼
$55.60
$2.71M0.2185,119 shs17,731 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00%0.00%0.00%0.00%-83.50%
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
0.00%-7.56%-16.35%-29.26%-85.72%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
0.00%+7.89%-18.56%-68.54%-95.24%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
0.00%-1.05%-20.11%-67.88%-94.20%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00
N/AN/AN/A
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
2.00
Hold$25.001,036.36% Upside
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.25
Hold$2.801,744.53% Upside
Beyond Air, Inc. stock logo
XAIR
Beyond Air
2.50
Moderate Buy$105.003,623.40% Upside

Current Analyst Ratings Breakdown

Latest DYNT, XAIR, VVOS, and VRAX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/1/2026
Beyond Air, Inc. stock logo
XAIR
Beyond Air
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$10.00
7/21/2026
Beyond Air, Inc. stock logo
XAIR
Beyond Air
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/17/2026
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/6/2026
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 10/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dynatronics Co. stock logo
DYNT
Dynatronics
$33.60M0.00N/AN/A$0.57 per share0.00
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
$10K176.00N/AN/A$42.23 per share0.05
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$17.44M0.12N/AN/A($0.16) per share-0.95
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$7.68M0.35N/AN/A$9.41 per share0.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dynatronics Co. stock logo
DYNT
Dynatronics
-$2.70M-$1.35N/AN/AN/A-8.35%-41.81%-9.56%N/A
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
-$5.02MN/AN/AN/AN/AN/AN/AN/A12/2/2026 (Estimated)
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$21.17M-$1.90N/AN/AN/A-122.00%-2,325.64%-102.01%11/18/2026 (Estimated)
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$33.25M-$68.40N/AN/AN/A-435.71%-440.26%-98.50%11/10/2026 (Estimated)

Latest DYNT, XAIR, VVOS, and VRAX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$0.41-$0.31+$0.10-$0.31$5.63 million$5.15 million
8/13/2026Q1 2027
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$10.80-$11.00-$0.20-$11.00$1.93 million$1.77 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
N/AN/AN/AN/AN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/AN/AN/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Dynatronics Co. stock logo
DYNT
Dynatronics
0.25
1.21
0.60
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
N/A
9.97
9.97
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/A
0.21
0.21
Beyond Air, Inc. stock logo
XAIR
Beyond Air
7.81
3.31
3.12

Institutional Ownership

CompanyInstitutional Ownership
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
8.61%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
26.35%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
31.50%

Insider Ownership

CompanyInsider Ownership
Dynatronics Co. stock logo
DYNT
Dynatronics
2.90%
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
45.10%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.10%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
9.99%
CompanyEmployeesShares OutstandingFree FloatOptionable
Dynatronics Co. stock logo
DYNT
Dynatronics
20016.05 million8.11 millionNot Optionable
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
26800,000438,000Not Optionable
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
26813.90 million13.60 millionOptionable
Beyond Air, Inc. stock logo
XAIR
Beyond Air
54960,000862,000Optionable

Recent News About These Companies

Yi-Chien Lin Reports 14.8% Ownership Stake in Beyond Air, Inc. (NASDAQ: XAIR)
October 4 at 1:10 PM  |  kalkinemedia.comK
Beyond Air Formalizes CEO Agreement, Boosts CFO Compensation
September 24, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/beyond-air-formalizes-ceo-agreement-boosts-cfo-compensation?utm_source=marketbeat.com&utm_medium=referral
Beyond Air consensus price target lowered by 33.33% to $20.40
September 15, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/beyond-air-consensus-price-target-lowered-by-33-33-to-20-40/ar-AA2cfeWM
Lake Street initiates coverage of Beyond Air (XAIR) with buy recommendation
September 2, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/lake-street-initiates-coverage-of-beyond-air-xair-with-buy-recommendation/ar-AA2bqN19
Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference
September 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/02/3355096/0/en/beyond-air-to-participate-in-the-2026-cantor-global-healthcare-conference.html
Beyond Air Receives FDA Breakthrough Device Designation For LungFit GO In NTM-PD
August 31, 2026  |  rttnews.comhttps://www.rttnews.com/3687027/beyond-air-receives-fda-breakthrough-device-designation-for-lungfit-go-in-ntm-pd.aspx
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
August 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/31/3353255/0/en/beyond-air-receives-fda-breakthrough-device-designation-for-lungfit-go-to-treat-nontuberculous-mycobacterial-pulmonary-disease-ntm-pd.html
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
August 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/25/3350319/0/en/beyond-air-enters-definitive-agreement-to-sell-its-neuronos-stake-to-univo-pharmaceutical-industries-in-exchange-for-equity-and-milestone-payments.html
Beyond Air, Inc. Q1 2027 Earnings Call Summary
August 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/beyond-air-inc-q1-2027-210809536.html
Beyond Air (XAIR) Q1 2027 Earnings Call Transcript
August 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/beyond-air-xair-q1-2027-035834380.html
Beyond Air Inc (XAIR) (Q1 2027) Earnings Call Highlights: Strategic Financing and Pipeline ...
August 13, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/beyond-air-inc-xair-q1-230916103.html
Beyond Air Reports $1.8 Million Q2 Revenue, Reaffirms 2026 and 2027 Guidance as FDA Reviews Second-Generation LungFit PH System
August 13, 2026  |  quiverquant.comQ
Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
August 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344347/0/en/beyond-air-reports-financial-results-for-the-quarter-ended-june-30-2026-and-provides-corporate-update.html
Beyond Air Regains Nasdaq Compliance After Reverse Stock Split
August 6, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/beyond-air-regains-nasdaq-compliance-after-reverse-stock-split?utm_source=marketbeat.com&utm_medium=referral
Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026
August 4, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/beyond-air-schedules-conference-call-to-discuss-financial-results-for-the-quarter-ended-june-30-2026-1036405717
Daniel Moorhead Purchases 4,340 Shares of Beyond Air (NASDAQ:XAIR) Stock
August 1, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-xair-insider-buying-and-selling-2026-08-01/
Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules
July 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/30/3335916/0/en/beyond-air-announces-up-to-30-1-million-private-placement-offering-priced-at-the-market-under-nasdaq-rules.html
Beyond Air Implements Reverse Stock Split to Maintain Listing
July 9, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/beyond-air-implements-reverse-stock-split-to-maintain-listing?utm_source=marketbeat.com&utm_medium=referral
Beyond Air (XAIR) Q4 2026 Earnings Call Transcript
June 26, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/beyond-air-xair-q4-2026-003158976.html?fr=sycsrp_catchall
Beyond Air Inc (XAIR) Q4 2026 Earnings Call Highlights: Revenue Surge and Path to Profitability
June 26, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/beyond-air-inc-xair-q4-190022679.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Dynatronics stock logo

Dynatronics NASDAQ:DYNT

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Virax Biolabs Group stock logo

Virax Biolabs Group NASDAQ:VRAX

$2.20 0.00 (0.00%)
Closing price 10/2/2026 03:54 PM Eastern
Extended Trading
$2.47 +0.27 (+12.09%)
As of 06:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name. It also develops T-Cell IVD test kit for COVID-19, which intend to adapt for immunological profiling against multiple viral threats under the ViraxImmune Brand, as well as a proprietary mobile application for ViraxImmune that presents an individual's immunological profiling data and provide advice on the users' immune system. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, pharmaceutical companies, research institutions, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.

Vivos Therapeutics stock logo

Vivos Therapeutics NASDAQ:VVOS

$0.15 0.00 (0.00%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$0.15 0.00 (-3.16%)
As of 06:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

Beyond Air stock logo

Beyond Air NASDAQ:XAIR

$2.82 0.00 (0.00%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$2.82 +0.00 (+0.14%)
As of 05:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas